Xencor (XNCR)
(Delayed Data from NSDQ)
$19.18 USD
-0.72 (-3.62%)
Updated Aug 2, 2024 04:00 PM ET
After-Market: $19.19 +0.01 (0.05%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth F Momentum F VGM
Industry / Sector Report
Industry : Medical - Drugs
Zacks Industry Rank
Bottom 39% (154 out of 251)Zacks Sector Rank
Top 25% (4 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.50 | 1.52 | 9.99 |
Current Quarter Estimate | -0.85 | -2.04 | 61.00 |
Year Ago Quarter Estimate | -0.37 | -0.59 | 54.84 |
Next Quarter Estimate | -0.82 | -2.00 | 63.00 |
Next Year Estimate | -3.21 | 6.92 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | -71.15 | 14.00 | 15.67 |
Next Year | 9.83 | 16.30 | 11.34 |
Last 5 Years | -284.10 | 7.00 | 8.10 |
Next 5 Years | NA | 24.90 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -5.88 |
Price/Book (MRQ) | 1.93 | 1.84 |
Price/Cash Flow (MRFY) | NA | 8.95 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -82.23% | -13.40% |
Return on Equity (TTM) | -20.29% | -71.77% |
Debt to Equity (MRQ) | NA | 0.04 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.